Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study.
- Published In:
- Lancet (London, England), 406(10499), 149-162 (2025)
- Authors:
- Dahl, Kirsten(3), Toubro, Søren, Dey, Sohan, Duque do Vale, Ruben, Flint, Anne, Gasiorek, Agnes, Heydorn, Arne, Jastreboff, Ania M, Key, Cassandra, Petersen, Signe Beck, Vegge, Andreas, Adelborg, Kasper
- Database ID:
- RPEP-10589
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10589APA
Dahl, Kirsten; Toubro, Søren; Dey, Sohan; Duque do Vale, Ruben; Flint, Anne; Gasiorek, Agnes; Heydorn, Arne; Jastreboff, Ania M; Key, Cassandra; Petersen, Signe Beck; Vegge, Andreas; Adelborg, Kasper. (2025). Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study.. Lancet (London, England), 406(10499), 149-162. https://doi.org/10.1016/S0140-6736(25)01185-7
MLA
Dahl, Kirsten, et al. "Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study.." Lancet (London, 2025. https://doi.org/10.1016/S0140-6736(25)01185-7
RethinkPeptides
RethinkPeptides Research Database. "Amycretin, a novel, unimolecular GLP-1 and amylin receptor a..." RPEP-10589. Retrieved from https://rethinkpeptides.com/research/dahl-2025-amycretin-a-novel-unimolecular
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.